Literature DB >> 8777856

Hypocalcaemia and chronic alcohol intoxication: transient hypoparathyroidism secondary to magnesium deficiency.

C Hermans1, C Lefebvre, J P Devogelaer, M Lambert.   

Abstract

The authors report the observation of an alcoholic patient admitted for tetanic manifestations, in whom severe hypocalcaemia associated with hyperphosphatemia were suggestive of hypoparathyroidism. Administration of magnesium supplementation alone improved the clinical features and led to the correction of the calcium abnormalities. The mechanisms of hypomagnesemia in alcohol intoxication are reviewed as well as the links with hypocalcaemia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8777856     DOI: 10.1007/bf02230340

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  30 in total

1.  Letter: Hypomagnessemia as a cause of persistent hypokalemia.

Authors:  S Webb; D S Schade
Journal:  JAMA       Date:  1975-07-07       Impact factor: 56.272

2.  The magnesium-deficiency tetany syndrome in man.

Authors:  B L VALLEE; W E WACKER; D D ULMER
Journal:  N Engl J Med       Date:  1960-01-28       Impact factor: 91.245

3.  Hypomagnesemic hypocalcemia. Early serum calcium and late parathyroid hormone increase with magnesium therapy.

Authors:  T Wiegmann; M Kaye
Journal:  Arch Intern Med       Date:  1977-07

Review 4.  Cyclic adenosine monophosphate and clinical medicine. I.

Authors:  M W Bitensky; J J Keirns; J Freeman
Journal:  Am J Med Sci       Date:  1973-11       Impact factor: 2.378

5.  Regulation of parathyroid hormone secretion by adrenyl cyclase.

Authors:  M Abe; L M Sherwood
Journal:  Biochem Biophys Res Commun       Date:  1972-07-25       Impact factor: 3.575

6.  Hypocalcemia due to hypomagnesemia and reversible parathyroid hormone unresponsiveness.

Authors:  H Estep; W A Shaw; C Watlington; R Hobe; W Holland; S G Tucker
Journal:  J Clin Endocrinol Metab       Date:  1969-06       Impact factor: 5.958

Review 7.  Guanine nucleotide-binding regulatory proteins and dual control of adenylate cyclase.

Authors:  A G Gilman
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

8.  Renal cortical adenylate cyclase: characterization of magnesium activation.

Authors:  R K Rude
Journal:  Endocrinology       Date:  1983-10       Impact factor: 4.736

9.  Pathogenesis of hypocalcemia in primary hypomagnesemia: normal end-organ responsiveness to parathyroid hormone, impaired parathyroid gland function.

Authors:  S M Suh; A H Tashjian; N Matsuo; D K Parkinson; D Fraser
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

10.  Pathogenesis of hypocalcemia in magnesium depletion. Normal end-organ responsiveness to parathyroid hormone.

Authors:  S M Suh; A Csima; D Fraser
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

View more
  5 in total

Review 1.  Hypomagnesemia and hypermagnesemia.

Authors:  Joel Michels Topf; Patrick T Murray
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

2.  Magnesium for treating sickle cell disease.

Authors:  Nan Nitra Than; Htoo Htoo Kyaw Soe; Senthil K Palaniappan; Adinegara Bl Abas; Lucia De Franceschi
Journal:  Cochrane Database Syst Rev       Date:  2019-09-09

3.  Antibody-mediated inhibition of EGFR reduces phosphate excretion and induces hyperphosphatemia and mild hypomagnesemia in mice.

Authors:  Bernardo Ortega; Jason M Dey; Allison R Gardella; Jacob Proano; Deanna Vaneerde
Journal:  Physiol Rep       Date:  2017-03

4.  Concomitant Fahr's syndrome and thoracic ossification of the posterior longitudinal ligament caused by idiopathic hypoparathyroidism - case report.

Authors:  Ikchan Jeon; Kyu Hyang Cho; Sang Woo Kim
Journal:  BMC Musculoskelet Disord       Date:  2019-08-07       Impact factor: 2.362

5.  Suppression of Parathyroid Hormone in a Patient with Severe Magnesium Depletion.

Authors:  Sangeeta Mutnuri; Isaac Fernandez; Tina Kochar
Journal:  Case Rep Nephrol       Date:  2016-04-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.